TXMD - TherapeuticsMD, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

TXMD

THERAPEUTICSMD, INC.

NASDAQ

$2.22

▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$25.70 M

52w High$2.95

52w Low$0.99

Dividend Yield—

Frequency—

P/E113.09

Volume19.33K

Shares Out.11.57M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Marlan D. Walker

COMPENSATION 2026

Salary$500,000

Stock Awards$0

Incentive Plan Pay$250,000

All Other Comp.$9,174

Total$759,174

ABOUT

SECTOR

Healthcare

WENT PUBLIC

May 9, 2007

METHOD OF GOING PUBLIC

Reverse Merger

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateNov 17, 2026

DayTuesday

Rev. Est.$19.77M

NOV

TUE

SPLIT RECORD

DATE	TYPE	RATIO
2022-05-09	Reverse	1:50
2011-10-31	Reverse	1:100
2011-10-03	Reverse	1:100
2009-09-28	Forward	3:1
2009-07-27	Forward	3:1

PRICE

$2.22 ▲ UP 0.00% (+$0.00)

OVERLAYS

About TherapeuticsMD, Inc.

https://www.therapeuticsmd.com ↗

TherapeuticsMD, Inc. is a U.S. women’s healthcare company developing and marketing prescription therapies, contraceptives, and prenatal vitamins, including IMVEXXY, BIJUVA, and ANNOVERA.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A SERVICE THERAPEUTICSMD, INC. IS KNOWN FOR

Pharmaceutical Royalty Management

TherapeuticsMD is now a pharmaceutical royalty company managing IP and licensing for women’s health products like ANNOVERA, BIJUVA, and IMVEXXY, earning royalties from their commercialization by partner Mayne Pharma.